The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
Open accessAbstract
Natural killer (NK) cells contribute to the first line of defense against viruses and to the control of tumor growth and metastasis spread. The discovery of HLA class I specific inhibitory receptors, primarily of killer Ig-like receptors (KIRs), and of activating receptors has been fundamental to unravel NK cell function and the molecular mechanisms of tumor cell killing. Stemmed from the seminal discoveries in early ‘90s, in which Alessandro Moretta was the major actor, an extraordinary amount of research on KIR specificity, genetics, polymorphism and repertoire has followed. These basic notions on NK cells and their receptors have been successfully translated to clinical applications, primarily to the haploidentical haematopoietic stem cell transplantation to cure otherwise fatal leukemia in patients with no HLA compatible donors. The finding that NK cells may express the PD-1 inhibitory checkpoint, particularly in cancer patients, may allow to understand how anti-PD-1 therapy could function also in case of HLA class Ineg tumors, usually susceptible to NK-mediated killing. This, together with the synergy of therapeutic anti-checkpoint monoclonal antibodies, including those directed against NKG2A or KIRs, emerging in recent or ongoing studies, opened new solid perspectives in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Ishida, Y., Agata, Y., Shibahara, K., & Honjo, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05481.x · Cited by 3,256
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687 · cited 2×
“In late ‘80s, the “missing self-hypothesis,” proposed by Karre and Ljunggren, inspired the subsequent seminal discoveries in mice and humans in early ‘90s (5).”
BackgroundHLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Innate Lymphoid Cells: 10 Years On
Vivier, E., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.017 · Cited by 2,124
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Self-citationThe IPD and IMGT/HLA database: allele variant databases
Robinson, J., Halliwell, J. A., Hayhurst, J. D., Flicek, P., Parham, P., & Marsh, S. G. E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1161 · Cited by 1,740
The biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340
André, P., Denis, C., Soulas, C., Bourbon-Caillet, C., Lopez, J., Arnoux, T., Bléry, M., Bonnafous, C., Gauthier, L., Morel, A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.014 · Cited by 1,221
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V., Frassati, C., Reviron, D., Middleton, D., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.013 · Cited by 1,211
MHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
Aversa, F., Tabilio, A., Velardi, A., Cunningham, I., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391702 · Cited by 1,168
Human Diversity in Killer Cell Inhibitory Receptor Genes
Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B., Tyan, D., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80394-5 · Cited by 1,059
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 986
Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., & Phillips, J. H. (1998) · Nature · doi:10.1038/35642 · Cited by 904
Bottino, C., Castriconi, R., Pende, D., Rivera, P., Nanni, M., Carnemolla, B., Cantoni, C., Grassi, J., Marcenaro, S., Reymond, N., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030788 · Cited by 875
Self-citationRECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Self-citationPende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
Self-citationSchlums, H., Cichocki, F., Tesi, B., Theorell, J., Beziat, V., Holmes, T. D., Han, H., Chiang, S. C. C., Foley, B., Mattsson, K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.008 · Cited by 787
Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80426-4 · Cited by 762
Self-citationVitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748
Self-citationColonna, M., & Samaridis, J. (1995) · Science · doi:10.1126/science.7716543 · Cited by 736
Björkström, N. K., Riese, P., Heuts, F., Andersson, S., Fauriat, C., Ivarsson, M. A., Björklund, A. T., Flodström-Tullberg, M., Michaëlsson, J., Rottenberg, M. E., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281675 · Cited by 734
The Broad Spectrum of Human Natural Killer Cell Diversity
Freud, A. G., Mundy-Bosse, B. L., Yu, J., & Caligiuri, M. A. (2017) · Immunity · doi:10.1016/j.immuni.2017.10.008 · Cited by 695
Foley, B., Cooley, S., Verneris, M. R., Pitt, M., Curtsinger, J., Luo, X., Lopez-Vergès, S., Lanier, L. L., Weisdorf, D., & Miller, J. S. (2012) · Blood · doi:10.1182/blood-2011-10-386995 · Cited by 630
Plasticity in the organization and sequences of human KIR/ILT gene families
Wilson, M. J., Torkar, M., Haude, A., Milne, S., Jones, T., Sheer, D., Beck, S., & Trowsdale, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080588597 · Cited by 624
Genetic and Environmental Determinants of Human NK Cell Diversity Revealed by Mass Cytometry
Horowitz, A., Strauss-Albee, D. M., Leipold, M., Kubo, J., Nemat-Gorgani, N., Dogan, O. C., Dekker, C. L., Mackey, S., Maecker, H., Swan, G. E., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006702 · Cited by 592
Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.953 · Cited by 579
Self-citationWagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M. S., Vitale, M., Bottino, C., Moretta, L., Moretta, A., & Long, E. O. (1995) · Immunity · doi:10.1016/1074-7613(95)90025-x · Cited by 578
Self-citationHuman NK cells: surface receptors, inhibitory checkpoints, and translational applications
Sivori, S., Vacca, P., Del Zotto, G., Munari, E., Mingari, M. C., & Moretta, L. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0206-4 · Cited by 555
Self-citationp46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., & Moretta, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1129 · Cited by 554
Self-citationMoretta, A., Vitale, M., Bottino, C., Orengo, A. M., Morelli, L., Augugliaro, R., Barbaresi, M., Ciccone, E., & Moretta, L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.597 · Cited by 534
Self-citationBéziat, V., Liu, L. L., Malmberg, J.-A., Ivarsson, M. A., Sohlberg, E., Björklund, A. T., Retière, C., Sverremark-Ekström, E., Traherne, J., Ljungman, P., et al. (2013) · Blood · doi:10.1182/blood-2012-10-459545 · Cited by 512
Gumperz, J. E., Litwin, V, Phillips, J. H., Lanier, L. L., & Parham, P. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1133 · Cited by 509
Costello, R. T., Sivori, S., Marcenaro, E., Lafage-Pochitaloff, M., Mozziconacci, M.-J., Reviron, D., Gastaut, J.-A., Pende, D., Olive, D., & Moretta, A. (2002) · Blood · doi:10.1182/blood.v99.10.3661 · Cited by 500
Self-citationRomagnani, C., Juelke, K., Falco, M., Morandi, B., D’Agostino, A., Costa, R., Ratto, G., Forte, G., Carrega, P., Lui, G., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4947 · Cited by 494
Self-citationX-Linked Lymphoproliferative Disease
Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H. D., Wolf, H., Bonnefoy, J.-Y., Biassoni, R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.337 · Cited by 477
Self-citationParham, P., & Moffett, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3370 · Cited by 476
Pesce, S., Greppi, M., Tabellini, G., Rampinelli, F., Parolini, S., Olive, D., Moretta, L., Moretta, A., & Marcenaro, E. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.04.025 · Cited by 465
Self-citationYokoyama, W. M., & Seaman, W. E. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003145 · Cited by 461
Colonna, M., Borsellino, G., Falco, M., Ferrara, G. B., & Strominger, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12000 · Cited by 460
Self-citationCantoni, C., Bottino, C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., & Biassoni, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.787 · Cited by 452
Self-citationIPD—the Immuno Polymorphism Database
Robinson, J., Mistry, K., McWilliam, H., Lopez, R., & Marsh, S. G. E. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp879 · Cited by 447
Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C., & Moretta, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.875 · Cited by 447
Self-citationHsu, K. C., Chida, S., Geraghty, D. E., & Dupont, B. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.19004.x · Cited by 443
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
Hammer, Q., Rückert, T., Borst, E. M., Dunst, J., Haubner, A., Durek, P., Heinrich, F., Gasparoni, G., Babic, M., Tomic, A., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0082-6 · Cited by 423
Self-citationEffect of tumor cells and tumor microenvironment on NK‐cell function
Vitale, M., Cantoni, C., Pietra, G., Mingari, M. C., & Moretta, L. (2014) · European Journal of Immunology · doi:10.1002/eji.201344272 · Cited by 412
Self-citationRomagné, F., André, P., Spee, P., Zahn, S., Anfossi, N., Gauthier, L., Capanni, M., Ruggeri, L., Benson, D. M., Blaser, B. W., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206532 · Cited by 408
Recognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors
Stewart, C. A., Laugier-Anfossi, F., Vély, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L., Romagné, F., Ferracci, G., Arosa, F. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503594102 · Cited by 406
Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
Boyington, J. C., Motyka, S. A., Schuck, P., Brooks, A. G., & Sun, P. D. (2000) · Nature · doi:10.1038/35014520 · Cited by 404
Location and cellular stages of natural killer cell development
Yu, J., Freud, A. G., & Caligiuri, M. A. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.07.005 · Cited by 387
Moretta, A., Bottino, C., Pende, D., Tripodi, G., Tambussi, G., Viale, O., Orengo, A., Barbaresi, M., Merli, A., & Ciccone, E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1589 · Cited by 385
Self-citationHsu, K. C., Liu, X.-R., Selvakumar, A., Mickelson, E., O’Reilly, R. J., & Dupont, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5118 · Cited by 381
Moesta, A. K., Norman, P. J., Yawata, M., Yawata, N., Gleimer, M., & Parham, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3969 · Cited by 379
Pende, D., Marcenaro, S., Falco, M., Martini, S., Bernardo, M. E., Montagna, D., Romeo, E., Cognet, C., Martinetti, M., Maccario, R., et al. (2009) · Blood · doi:10.1182/blood-2008-06-164103 · Cited by 378
Self-citationPende, D., Biassoni, R., Cantoni, C., Verdiani, S., Falco, M., di Donato, C., Accame, L., Bottino, C., Moretta, A., & Moretta, L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.505 · Cited by 365
Self-citationA human killer inhibitory receptor specific for HLA-A1,2
Döhring, C., Scheidegger, D., Samaridis, J., Cella, M., & Colonna, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3098 · Cited by 349
NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.
Litwin, V, Gumperz, J., Parham, P., Phillips, J. H., & Lanier, L. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.537 · Cited by 348
Biassoni, R., Cantoni, C., Falco, M., Verdiani, S., Bottino, C., Vitale, M., Conte, R., Poggi, A., Moretta, A., & Moretta, L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.645 · Cited by 342
Self-citationNKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
van Montfoort, N., Borst, L., Korrer, M. J., Sluijter, M., Marijt, K. A., Santegoets, S. J., van Ham, V. J., Ehsan, I., Charoentong, P., André, P., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.028 · Cited by 333
Genetic and Functional Relationships between MHC and NK Receptor Genes
Trowsdale, J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00197-2 · Cited by 321
Recognition of HLA‐A3 and HLA‐A11 by KIR3DL2 is peptide‐specific
Hansasuta, P., Dong, T., Thananchai, H., Weekes, M., Willberg, C., Aldemir, H., Rowland‐Jones, S., & Braud, V. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200425089 · Cited by 318
Locatelli, F., Merli, P., Pagliara, D., Li Pira, G., Falco, M., Pende, D., Rondelli, R., Lucarelli, B., Brescia, L. P., Masetti, R., et al. (2017) · Blood · doi:10.1182/blood-2017-04-779769 · Cited by 316
Self-citationThe genomic context of natural killer receptor extended gene families
Trowsdale, J., Barten, R., Haude, A., Stewart, C. A., Beck, S., & Wilson, M. J. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810102.x · Cited by 314
Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes
D'Andrea, A., Chang, C., Franz-Bacon, K., McClanahan, T., Phillips, J. H., & Lanier, L. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2306 · Cited by 310
Bottino, C., Falco, M., Parolini, S., Marcenaro, E., Augugliaro, R., Sivori, S., Landi, E., Biassoni, R., Notarangelo, L. D., Moretta, L., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.3.235 · Cited by 310
Self-citationEducation of human natural killer cells by activating killer cell immunoglobulin-like receptors
Fauriat, C., Ivarsson, M. A., Ljunggren, H.-G., Malmberg, K.-J., & Michaëlsson, J. (2010) · Blood · doi:10.1182/blood-2009-09-245746 · Cited by 305
Unifying concepts of MHC-dependent natural killer cell education
Elliott, J. M., & Yokoyama, W. M. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.001 · Cited by 279
Allelic Polymorphism Synergizes with Variable Gene Content to Individualize Human KIR Genotype
Shilling, H. G., Guethlein, L. A., Cheng, N. W., Gardiner, C. M., Rodriguez, R., Tyan, D., & Parham, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2307 · Cited by 275
Gardiner, C. M., Guethlein, L. A., Shilling, H. G., Pando, M., Carr, W. H., Rajalingam, R., Vilches, C., & Parham, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.2992 · Cited by 264
Olcese, L., Cambiaggi, A., Semenzato, G., Bottino, C., Moretta, A., & Vivier, E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5083 · Cited by 262
Rajagopalan, S., Fu, J., & Long, E. O. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1877 · Cited by 258
Della Chiesa, M., Falco, M., Podestà, M., Locatelli, F., Moretta, L., Frassoni, F., & Moretta, A. (2012) · Blood · doi:10.1182/blood-2011-08-372003 · Cited by 254
Self-citationMoretta, A., Tambussi, G., Bottino, C., Tripodi, G., Merli, A., Ciccone, E., Pantaleo, G., & Moretta, L. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.3.695 · Cited by 250
Self-citationOpen conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1
Garcia-Beltran, W. F., Hölzemer, A., Martrus, G., Chung, A. W., Pacheco, Y., Simoneau, C. R., Rucevic, M., Lamothe-Molina, P. A., Pertel, T., Kim, T.-E., et al. (2016) · Nature Immunology · doi:10.1038/ni.3513 · Cited by 243
Mingari, M. C., Ponte, M., Bertone, S., Schiavetti, F., Vitale, C., Bellomo, R., Moretta, A., & Moretta, L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1172 · Cited by 241
Self-citationMingari, M. C., Schiavetti, F., Ponte, M., Vitale, C., Maggi, E., Romagnani, S., Demarest, J., Pantaleo, G., Fauci, A. S., & Moretta, L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12433 · Cited by 240
Self-citationGraef, T., Moesta, A. K., Norman, P. J., Abi-Rached, L., Vago, L., Older Aguilar, A. M., Gleimer, M., Hammond, J. A., Guethlein, L. A., Bushnell, D. A., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091010 · Cited by 238
Pyo, C.-W., Guethlein, L. A., Vu, Q., Wang, R., Abi-Rached, L., Norman, P. J., Marsh, S. G. E., Miller, J. S., Parham, P., & Geraghty, D. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015115 · Cited by 236
IPD—the Immuno Polymorphism Database
Robinson, J., Halliwell, J. A., McWilliam, H., Lopez, R., & Marsh, S. G. E. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1140 · Cited by 234
Martin, A. M., Freitas, E. M., Witt, C. S., & Christiansen, F. T. (2000) · Immunogenetics · doi:10.1007/s002510050620 · Cited by 230
Vacca, P., Vitale, C., Montaldo, E., Conte, R., Cantoni, C., Fulcheri, E., Darretta, V., Moretta, L., & Mingari, M. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016257108 · Cited by 226
Self-citationIL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity
Molgora, M., Bonavita, E., Ponzetta, A., Riva, F., Barbagallo, M., Jaillon, S., Popović, B., Bernardini, G., Magrini, E., Gianni, F., et al. (2017) · Nature · doi:10.1038/nature24293 · Cited by 226
Class I HLA haplotypes form two schools that educate NK cells in different ways
Horowitz, A., Djaoud, Z., Nemat-Gorgani, N., Blokhuis, J., Hilton, H. G., Béziat, V., Malmberg, K.-J., Norman, P. J., Guethlein, L. A., & Parham, P. (2016) · Science Immunology · doi:10.1126/sciimmunol.aag1672 · Cited by 225
KIR3DL1 Polymorphisms That Affect NK Cell Inhibition by HLA-Bw4 Ligand
Carr, W. H., Pando, M. J., & Parham, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5222 · Cited by 224
Identification of NKp80, a novel triggering molecule expressed by human NK cells
Vitale, M., Falco, M., Castriconi, R., Parolini, S., Zambello, R., Semenzato, G., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200101)31:1<233::aid-immu233>3.0.co;2-4 · Cited by 223
Self-citationFalco, M., Biassoni, R., Bottino, C., Vitale, M., Sivori, S., Augugliaro, R., Moretta, L., & Moretta, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.6.793 · Cited by 222
Self-citationMingari, M. C., Vitale, C., Cambiaggi, A., Schiavetti, F., Melioli, G., Ferrini, S., & Poggi, A. (1995) · International Immunology · doi:10.1093/intimm/7.4.697 · Cited by 219
Self-citationCiccone, E., Pende, D., Viale, O., Than, A., Di Donato, C., Orengo, A. M., Biassoni, R., Verdiani, S., Amoroso, A., & Moretta, A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.963 · Cited by 214
Self-citationBiassoni, R., Pessino, A., Malaspina, A., Cantoni, C., Bottino, C., Sivori, S., Moretta, L., & Moretta, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271203 · Cited by 213
Self-citationPando, M. J., Gardiner, C. M., Gleimer, M., McQueen, K. L., & Parham, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6640 · Cited by 212
Natural killer cell specificity for viral infections
Hammer, Q., Rückert, T., & Romagnani, C. (2018) · Nature Immunology · doi:10.1038/s41590-018-0163-6 · Cited by 202
Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups
Chandanayingyong, D., Vaughan, R. W., Verity, D. H., Norman, P. J., & Stephens, H. A. F. (2001) · Immunogenetics · doi:10.1007/s002510000281 · Cited by 200
Bertone, S., Schiavetti, F., Bellomo, R. G., Vitale, C., Ponte, M., Moretta, L., & Mingari, M. C. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199901)29:01<23::aid-immu23>3.0.co;2-y · Cited by 195
Self-citationCiccone, E., Pende, D., Viale, O., Di Donato, C., Tripodi, G., Orengo, A. M., Guardiola, J., Moretta, A., & Moretta, L. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.3.709 · Cited by 187
Self-citationKIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro
Chewning, J. H., Gudme, C. N., Hsu, K. C., Selvakumar, A., & Dupont, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.854 · Cited by 186
Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned
Boudreau, J. E., & Hsu, K. C. (2018) · Trends in Immunology · doi:10.1016/j.it.2017.12.001 · Cited by 184
Facilitation of KIR genotyping by a PCR‐SSP method that amplifies short DNA fragments
Vilches, C., Castaño, J., Gómez‐Lozano, N., & Estefanía, E. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00923.x · Cited by 182
Dissecting CD56dim human NK cells
Moretta, L. (2010) · Blood · doi:10.1182/blood-2010-09-303057 · Cited by 181
Self-citationBenson, D. M., Cohen, A. D., Jagannath, S., Munshi, N. C., Spitzer, G., Hofmeister, C. C., Efebera, Y. A., Andre, P., Zerbib, R., & Caligiuri, M. A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0304 · Cited by 180
Jiang, W., Johnson, C., Jayaraman, J., Simecek, N., Noble, J., Moffatt, M. F., Cookson, W. O., Trowsdale, J., & Traherne, J. A. (2012) · Genome Research · doi:10.1101/gr.137976.112 · Cited by 180
Hendricks, D. W., Balfour, H. H., Dunmire, S. K., Schmeling, D. O., Hogquist, K. A., & Lanier, L. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303211 · Cited by 177
Co‐evolution of NK receptors and HLA ligands in humans is driven by reproduction
Moffett, A., & Colucci, F. (2015) · Immunological Reviews · doi:10.1111/imr.12323 · Cited by 174
Colonna, M., Spies, T. A., Strominger, J. L., Ciccone, E., Moretta, A., Moretta, L., Pende, D., & Viale, O. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.7983 · Cited by 170
Self-citationMunari, E., Zamboni, G., Lunardi, G., Marchionni, L., Marconi, M., Sommaggio, M., Brunelli, M., Martignoni, G., Netto, G. J., Hoque, M. O., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.04.017 · Cited by 170
Self-citationDefining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing
Norman, P. J., Hollenbach, J. A., Nemat-Gorgani, N., Marin, W. M., Norberg, S. J., Ashouri, E., Jayaraman, J., Wroblewski, E. E., Trowsdale, J., Rajalingam, R., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.06.023 · Cited by 169
Different checkpoints in human NK-cell activation
MORETTA, L., BOTTINO, C., PENDE, D., VITALE, M., MINGARI, M., & MORETTA, A. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.008 · Cited by 166
Self-citationFunctional Polymorphism of the KIR3DL1/S1 Receptor on Human NK Cells
O’Connor, G. M., Guinan, K. J., Cunningham, R. T., Middleton, D., Parham, P., & Gardiner, C. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.235 · Cited by 162
Mingari, M. C., Vitale, C., Cantoni, C., Bellomo, R., Ponte, M., Schiavetti, F., Bertone, S., Moretta, A., & Moretta, L. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270612 · Cited by 161
Self-citationChiesa, M. D., Falco, M., Bertaina, A., Muccio, L., Alicata, C., Frassoni, F., Locatelli, F., Moretta, L., & Moretta, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302053 · Cited by 160
Self-citationEffects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
Ruggeri, L., Urbani, E., Andre, P., Mancusi, A., Tosti, A., Topini, F., Blery, M., Animobono, L., Romagne, F., Wagtmann, N., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.135301 · Cited by 160
Cantoni, C., Bottino, C., Augugliaro, R., Morelli, L., Marcenaro, E., Castriconi, R., Vitale, M., Pende, D., Sivori, S., Millo, R., et al. (1999) · European Journal of Immunology · Cited by 153
Self-citationHLA-F and MHC Class I Open Conformers Are Ligands for NK Cell Ig-like Receptors
Goodridge, J. P., Burian, A., Lee, N., & Geraghty, D. E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300081 · Cited by 149
Locatelli, F., Pende, D., Falco, M., Chiesa, M. D., Moretta, A., & Moretta, L. (2018) · Trends in immunology · doi:10.1016/j.it.2018.04.009 · Cited by 138
Self-citationNatural killer cell education in human health and disease
Boudreau, J. E., & Hsu, K. C. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.11.003 · Cited by 137
Cutting Edge: Expansion of the KIR Locus by Unequal Crossing Over
Martin, M. P., Bashirova, A. A., Traherne, J. A., Trowsdale, J., & Carrington, M. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2192 · Cited by 134
CD4+ cutaneous T-cell lymphoma cells express the p140–killer cell immunoglobulin-like receptor
Bagot, M., Moretta, A., Sivori, S., Biassoni, R., Cantoni, C., Bottino, C., Boumsell, L., & Bensussan, A. (2001) · Blood · doi:10.1182/blood.v97.5.1388 · Cited by 131
Self-citationFeatures of Memory-Like and PD-1+ Human NK Cell Subsets
Chiesa, M. D., Pesce, S., Muccio, L., Carlomagno, S., Sivori, S., Moretta, A., & Marcenaro, E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00351 · Cited by 125
Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen.
Pérez‐Villar, J. J., Melero, I., Rodrı́guez, A., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.5779 · Cited by 123
Selvakumar, A., Steffens, U., & Dupont, B. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02647.x · Cited by 119
Sivori, S., Falco, M., Carlomagno, S., Romeo, E., Soldani, C., Bensussan, A., Viola, A., Moretta, L., & Moretta, A. (2010) · Blood · doi:10.1182/blood-2009-12-256586 · Cited by 118
Self-citationMeiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypesPreprint
Norman, P. J., Abi‐Rached, L., Gendzekhadze, K., Hammond, J. A., Moesta, A. K., Sharma, D., Graef, T. T., McQueen, K. L., Guethlein, L. A., Carrington, C. V. F., et al. (2009) · Genome Research · doi:10.1101/gr.085738.108 · Cited by 118
Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes
Hilton, H. G., Guethlein, L. A., Goyos, A., Nemat‐Gorgani, N., Bushnell, D. A., Norman, P. J., & Parham, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501358 · Cited by 114
Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture.
Ciccone, E., Viale, O., Pende, D., Malnati, M., Biassoni, R., Melioli, G., Moretta, A., Long, E. O., & Moretta, L. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.6.2403 · Cited by 113
Self-citationMunari, E., Zamboni, G., Marconi, M., Sommaggio, M., Brunelli, M., Martignoni, G., Netto, G. J., Moretta, F., Mingari, M. C., Salgarello, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21485 · Cited by 112
Self-citationKärre, K. (2002) · Science · doi:10.1126/science.1070538 · Cited by 109
Human KIR repertoires: shaped by genetic diversity and evolution
Manser, A., Weinhold, S., & Uhrberg, M. (2015) · Immunological Reviews · doi:10.1111/imr.12316 · Cited by 108
Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex
Traherne, J. A., Martin, M. P., Ward, R. D., Ohashi, M., Pellett, F., Gladman, D. D., Middleton, D., Carrington, M. N., & Trowsdale, J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp538 · Cited by 106
Shaping of NK Cell Responses by the Tumor Microenvironment
Stojanovic, A., Correia, M. P., & Cerwenka, A. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0125-8 · Cited by 105
Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine245
Bari, R., Bell, T., Leung, W., Vong, Q. P., Chan, W. K., Gupta, N., Holladay, M. S., Rooney, B., & Leung, W. H. (2009) · Blood · doi:10.1182/blood-2009-07-231977 · Cited by 104
Pietra, G., Romagnani, C., Falco, M., Vitale, M., Castriconi, R., Pende, D., Millo, E., Anfossi, S., Biassoni, R., Moretta, L., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200112)31:12<3687::aid-immu3687>3.0.co;2-c · Cited by 101
Self-citationInhibitory MHC class I receptors on NK and T cells: a standard nomenclature
Long, E. O., Colonna, M., & Lanier, L. L. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80590-1 · Cited by 100
David, G., Djaoud, Z., Willem, C., Legrand, N., Rettman, P., Gagne, K., Cesbron, A., & Retière, C. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301580 · Cited by 98
Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11
Liu, J., Xiao, Z., Ko, H. L., Shen, M., & Ren, E. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322052111 · Cited by 98
KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C
Naiyer, M. M., Cassidy, S. A., Magri, A., Cowton, V. M., Chen, K. C., Mansour, S., Kranidioti, H., Mbiribindi, B., Rettman, P., Harris, S., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aal5296 · Cited by 98
Muccio, L., Bertaina, A., Falco, M., Pende, D., Meazza, R., López‐Botet, M., Moretta, L., Locatelli, F., Moretta, A., & Chiesa, M. D. (2015) · Haematologica · doi:10.3324/haematol.2015.134155 · Cited by 94
Self-citationNK-CTLs, a novel HLA-E-restricted T-cell subset
Moretta, L., Romagnani, C., Pietra, G., Moretta, A., & Mingari, M. C. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00031-0 · Cited by 93
Self-citationMissing or altered self: human NK cell receptors that recognize HLA-C
Hilton, H. G., & Parham, P. (2017) · Immunogenetics · doi:10.1007/s00251-017-1001-y · Cited by 93
Munari, E., Rossi, G., Zamboni, G., Lunardi, G., Marconi, M., Sommaggio, M., Netto, G. J., Hoque, M. O., Brunelli, M., Martignoni, G., et al. (2018) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001105 · Cited by 88
Self-citationGómez‐Lozano, N., Estefanía, E., Williams, F., Halfpenny, I. A., Middleton, D., Solís, R., & Vilches, C. (2004) · European Journal of Immunology · doi:10.1002/eji.200425493 · Cited by 81
Recombinant structures expand and contract inter and intragenic diversification at the KIR locus
Pyo, C., Wang, R., Vu, Q., Cereb, N., Yang, S. Y., Duh, F.-M. C., Wolinsky, S. M., Martin, M. P., Carrington, M. N., & Geraghty, D. E. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-89 · Cited by 79
Lanier, L. L., Gumperz, J. E., Parham, P., Melero, I., López‐Botet, M., & Phillips, J. H. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.7.3320 · Cited by 78
VandenBussche, C. J., Mulrooney, T. J., Frazier, W. R., Dakshanamurthy, S., & Hurley, C. K. (2008) · Genes and Immunity · doi:10.1038/gene.2008.91 · Cited by 76
Frazier, W. R., Steiner, N., Hou, L., Dakshanamurthy, S., & Hurley, C. K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300464 · Cited by 76
Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C
Sim, M. J. W., Rajagopalan, S., Altmann, D., Boyton, R., Sun, P., & Long, E. O. (2019) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1903781116 · Cited by 75
Vitale, M., Sivori, S., Pende, D., Moretta, L., & Moretta, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3536 · Cited by 69
Self-citationEvidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function
Chiesa, M. D., Romeo, E., Falco, M., Balsamo, M., Augugliaro, R., Moretta, L., Bottino, C., Moretta, A., & Vitale, M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838434 · Cited by 68
Self-citationParham, P. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.11.016 · Cited by 68
Goodridge, J. P., Lathbury, L. J., Steiner, N., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200636316 · Cited by 67
Blokhuis, J. H., Hilton, H. G., Guethlein, L. A., Norman, P. J., Nemat‐Gorgani, N., Nakimuli, A., Chazara, O., Moffett, A., & Parham, P. (2017) · Immunity Inflammation and Disease · doi:10.1002/iid3.178 · Cited by 62
Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?
Vacca, P., Munari, E., Tumino, N., Moretta, F., Pietra, G., Vitale, M., Zotto, G. D., Mariotti, F. R., Mingari, M. C., & Moretta, L. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.11.004 · Cited by 58
Self-citationImpact of HCMV Infection on NK Cell Development and Function after HSCT
Chiesa, M. D., Falco, M., Muccio, L., Bertaina, A., Locatelli, F., & Moretta, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00458 · Cited by 57
Self-citationvan der Ploeg, K., Chang, C., Ivarsson, M. A., Moffett, A., Wills, M. R., & Trowsdale, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00298 · Cited by 56
Sharma, D., Bastard, K., Guethlein, L. A., Norman, P. J., Yawata, N., Yawata, M., Pando, M. J., Thananchai, H., Dong, T., Rowland-Jones, S. L., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901734 · Cited by 55
Loss and Gain of Natural Killer Cell Receptor Function in an African Hunter-Gatherer Population
Hilton, H. G., Norman, P. J., Nemat‐Gorgani, N., Goyos, A., Hollenbach, J. A., Henn, B. M., Gignoux, C. R., Guethlein, L. A., & Parham, P. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005439 · Cited by 51
Sim, M. J. W., Malaker, S. A., Khan, A., Stowell, J. M., Shabanowitz, J., Peterson, M., Rajagopalan, S., Hunt, D. F., Altmann, D. M., Long, E. O., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00193 · Cited by 50
Influence of KIR Diversity on Human Immunity
Parham, P. (2007) · Springer eBooks · doi:10.1007/0-387-24180-9_6 · Cited by 48
Thiruchelvam‐Kyle, L., Hoelsbrekken, S. E., Saether, P. C., Bjørnsen, E. G., Pende, D., Fossum, S., Daws, M. R., & Dissen, E. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600930 · Cited by 46
Self-citationImmune Checkpoint Inhibitors: Anti-NKG2A Antibodies on Board
Mingari, M. C., Pietra, G., & Moretta, L. (2019) · Trends in Immunology · doi:10.1016/j.it.2018.12.009 · Cited by 43
Self-citationMuccio, L., Falco, M., Bertaina, A., Locatelli, F., Frassoni, F., Sivori, S., Moretta, L., Moretta, A., & Chiesa, M. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01050 · Cited by 40
Self-citationDiefenbach, A., Colonna, M., & Romagnani, C. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.008 · Cited by 36
Roberts, C. H., Jiang, W., Jayaraman, J., Trowsdale, J., Holland, M. J., & Traherne, J. A. (2014) · Genome Medicine · doi:10.1186/gm537 · Cited by 34
Carlomagno, S., Falco, M., Bono, M., Alicata, C., Garbarino, L., Mazzocco, M., Moretta, L., Moretta, A., & Sivori, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00581 · Cited by 31
Self-citationPupuleku, A., Costa-García, M., Farré, D., Hengel, H., Angulo, A., Muntasell, A., & López‐Botet, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01317 · Cited by 27
Cytomegalovirus in hematopoietic stem cell transplant recipients - management of infection
Locatelli, F., Bertaina, A., Bertaina, V., & Merli, P. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2016.1242406 · Cited by 25
Self-citationqKAT: a high-throughput qPCR method for KIR gene copy number and haplotype determination
Jiang, W., Johnson, C., Simecek, N., López-Álvarez, M. R., Di, D., Trowsdale, J., & Traherne, J. A. (2016) · Genome Medicine · doi:10.1186/s13073-016-0358-0 · Cited by 24
Extensive Variation in Gene Copy Number at the Killer Immunoglobulin-Like Receptor Locus in Humans
Vendelbosch, S., de Boer, M., Gouw, R. A. T. W., Ho, C. K. Y., Geissler, J., Swelsen, W. T. N., Moorhouse, M. J., Lardy, N. M., Roos, D., van den Berg, T. K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067619 · Cited by 20
van der Weyden, C., Bagot, M., Neeson, P. J., Darcy, P. K., & Prince, H. M. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1498081 · Cited by 16
KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding
Mulrooney, T. J., Zhang, A., Goldgur, Y., Boudreau, J. E., & Hsu, K. C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500243 · Cited by 14
Analysis of KIR3DP1 Polymorphism Provides Relevant Information on Centromeric KIR Gene Content
Bono, M., Pende, D., Bertaina, A., Moretta, A., Chiesa, M. D., Sivori, S., Zecca, M., Locatelli, F., Moretta, L., Bottino, C., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800564 · Cited by 10
Self-citationMoretta, L., & Mantovani, A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0075-5 · Cited by 2
Self-citationBischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Pan, K., Farrukh, H., Chittepu, V. C. S. R., Xu, H., Pan, C.-X., & Zhu, Z. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02327-z · Cited by 657
Maalej, K. M., Merhi, M., Inchakalody, V. P., Mestiri, S., Alam, M., Maccalli, C., Cherif, H., Uddin, S., Steinhoff, M., Marincola, F. M., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01723-z · Cited by 618
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Wolf, N. K., Kissiov, D. U., & Raulet, D. H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00732-1 · Cited by 577
Tumor-Infiltrating Natural Killer Cells
Cózar, B., Greppi, M., Carpentier, S., Narni-Mancinelli, E., Chiossone, L., & Vivier, E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0655 · Cited by 476
NK cells and ILCs in tumor immunotherapy
Sivori, S., Pende, D., Quatrini, L., Pietra, G., Della Chiesa, M., Vacca, P., Tumino, N., Moretta, F., Mingari, M. C., Locatelli, F., et al. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100870 · Cited by 270
Self-citation
Metadata
- Authors
- Pende, D., Falco, M., Vitale, M., Cantoni, C., Vitale, C., Munari, E., Bertaina, A., Moretta, F., Del Zotto, G., Pietra, G., Mingari, M. C., Locatelli, F., & Moretta, L.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-05-28
- Volume
- 10
- Pages
- 1179-1179
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2946946191
- Cited by
- 389
- References
- 173
- FWCI
- 14.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.